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B cells are generated from hematopoietic stem cells (HSCs)
in the liver during the fetal life, and in the bone marrow in
the adult. The differentiation pathway from HSC to mature
B cell can be divided into several stages, based on the pheno-
type and on functional properties that cells of the B lineage
progressively acquire. Progenitor B (pro-B) cells can be iden-
tified by cell surface expression of B220, CD43, and c-kit.
Differential expression of heat-stable antigen (HSA) and of
the maturation marker BP-1 discriminates four fractions of
 
pro-B cells (fractions A, B, C, and C
 
9
 
 [1]). At this stage of de-
velopment, DNA rearrangement begins in the Ig H chain lo-
cus. Most pro-B cells of fraction A carry Ig genes in germline
 
configuration. D
 
H
 
®
 
J
 
H
 
 rearrangements are found in almost all
cells of fraction B. V
 
H
 
®
 
 
 
D
 
H
 
J
 
H
 
 rearrangement occurs in frac-
tions C and C
 
9
 
 (2). Cells in fractions B to C
 
9
 
 are also called
pre-B I cells. As soon as 
 
m
 
H chain proteins appear in the cy-
toplasm and can be assembled into a functional precursor B
cell receptor (pre-BCR), pre-B I cells develop into large
pre-B II cells that are c-kit and CD43 negative (3). Successful
rearrangement of the H chain and a correctly assembled pre-
BCR associated with a functional signaling machinery allow
pre-B II cells to proliferate. How is this proliferation con-
trolled, what stimulates it, and what terminates it? When pro-
liferation stops, pre-B II cells become smaller (so-called small
pre-B II) and rearrangement starts again, this time in the L
chain locus. Immature B cells subsequently express a com-
plete IgM molecule on their surface. B cells leave the bone
marrow at the transitional B cell stage and complete their final
development into mature B cells in the periphery (4).
Analysis of mice with mutations of genes involved in the
rearrangement process and in BCR signaling has shown
that the pre-BCR (2) and the BCR (4) regulate the pro-
gression of cells of the B lineage along their differentiation
pathway at earlier and later stages of development, respec-
tively. However, the microenvironment in the bone mar-
row also plays a role of fundamental importance. When
HSCs are injected intravenously, long-term B cell poiesis is
established only in the bone marrow, suggesting that only
this microenvironment supports the growth and differenti-
ation of cells of the B lineage in the adult. The liver func-
tions as the site of hematopoiesis only transiently, during
the fetal life. Although stromal cells are the key elements of
the microenvironment of the bone marrow, very little is
known about their biological diversity and functional char-
acteristics (5). Stromal cells form a network in the intersi-
nusoidal spaces of the bone cavity that extends from the en-
dostium to the endothelial cell basement membrane of the
sinusoids. Hematopoietic cells differentiate and proliferate
in the interstices of this network in close contact with long
cytoplasmic processes of stromal cells (6, 7). One major func-
tion of stromal cells is the production of IL-7. IL-7 was
originally cloned from a stromal cell line as a factor sup-
porting the growth of pre-B cells in vitro. Because pre-B cells
do not grow on stromal cells that fail to produce IL-7, this
cytokine is an indispensable requirement for B cell devel-
opment (8). The receptor for IL-7 (IL-7R) on lymphocytes
 
is a heterodimer composed of an 
 
a
 
 and a 
 
g
 
c chain. The 
 
a
 
chain is shared by the IL-7R and by the receptor for the re-
cently identified cytokine thymic stromal lymphopoietin
(TSLP [9]). The common 
 
g
 
c chain is employed for signal-
ing purposes by receptors for IL-2, IL-4, IL-9, and IL-15 in
addition to IL-7 (10). The generation of mice deficient for
individual elements of the IL-7/IL-7R system has shed
light on the in vivo function of this cytokine. Mice that lack
 
IL-7 (11), the IL-7R 
 
a
 
 chain (12), or the common 
 
g
 
c chain
(13) all show a block of B cell development at the pro-B
stage. This results in a strong reduction of the pre-B cell
population and, consequently, of the mature B cell pool in
the periphery. The defect is more severe in mice lacking the
IL-7R 
 
a
 
 chain than in mice lacking IL-7 or the 
 
g
 
c. In the
 
IL-7R
 
a
 
2
 
/
 
2 
 
mice, D
 
H
 
-J
 
H
 
 recombination is not affected, but
germline transcription from distal unrearranged V segments
does not occur. This essentially blocks recombination of dis-
tal V
 
H
 
 segments (14). It has been shown that transcription
of V
 
H
 
 gene segments is controlled by the transcription fac-
 
tor Pax-5. The analysis of Pax-5
 
2
 
/
 
2
 
 mice has shown recently
that Pax-5 is indispensable for the irreversible commitment
of hematopoietic precursors cells to the B lineage. B cell
development is arrested at the pro-B cell stage in Pax-5
 
2
 
/
 
2
 
mice. Like normal pro-B cells, Pax-5
 
2
 
/
 
2
 
 pro-B cells un-
dergo D
 
H
 
J
 
H
 
 rearrangement, express B cell-specific genes,
and grow in vitro in the presence of IL-7. Surprisingly,
however, these pro-B cells are not committed to the B lin-
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eage, and maintain the ability to develop into other he-
matopoietic cell types in vitro (15) and in vivo (16). Inter-
estingly, expression of Pax-5 and of Pax-5–dependent
genes is reduced in IL-7R
 
a
 
–deficient mice (14). By aug-
menting Pax-5 expression, IL-7 may facilitate the commit-
ment of hematopoietic cells to the B lineage.
B cell development is also blocked at the pro-B cell stage
in IL-7
 
2
 
/
 
2
 
 mice (11). However, in this case, rearrangement
occurs, all fractions of pro-B cells develop, and a few ma-
ture B cells populate the spleen. This shows that although
differentiation of B cells proceeds unimpaired, the prolifera-
tive expansion of pre-B cells is abolished. This phenotype is
similar to that of 
 
g
 
c
 
2
 
/
 
2
 
 mice (13). Because V
 
H
 
®
 
D
 
H
 
J
 
H
 
 rear-
rangement is impaired only in IL-7R
 
a
 
–deficient mice, we
have to postulate that another factor at least partially re-
places the function of IL-7 in pro-B cells of mice deficient
for IL-7 or the 
 
g
 
c chain. TSLP is a good candidate for this
function, because it supports the differentiation of pre-B
cells into membrane-bound (m)IgM
 
1
 
 B cells in long-term
bone marrow cultures (LTBMCs) without inducing prolif-
eration. In addition, its receptor uses the IL-7R 
 
a
 
 chain,
but not the 
 
g
 
c chain (9).
A recent study has dissected the function of different
domains of the 
 
a
 
 chain of the IL-7R (17). Proliferation of
pro-B cells in response to IL-7 was abrogated by a single
mutation (Tyr449
 
®
 
Phe) in the cytoplasmic tail of the
IL-7R 
 
a
 
 chain, which prevents the recruitment of phos-
phatidylinositol-3 kinase (PI-3 kinase) upon ligand binding.
PI-3 kinase is indispensable for the induction of prolifera-
tion by many growth factors. The importance of PI-3 ki-
nase for the expansion of the pre-B cell pool was confirmed
by the analysis of mice deficient for the p-85
 
a
 
 subunit of
PI-3 kinase. In these mice, pro-B cells are present, but
pre-B cells are reduced, and only a few B cells can be
found in the periphery. The mutated IL-7R 
 
a
 
 chain retains
the ability to induce V
 
H
 
®
 
D
 
H
 
J
 
H
 
 rearrangement in pro-B
cells, showing that these two functions of the IL-7R are
physically separated in the cytoplasmic tail of the 
 
a
 
 chain.
In conclusion, IL-7 expands the diversity of the antibody
repertoire by inducing V
 
H
 
®
 
D
 
H
 
J
 
H
 
 rearrangement in pro-B
cells. The proliferation of the pre-B cells leads to the selec-
tive expansion of the cells, which have successfully rear-
ranged the H chain and express a functional pre-BCR.
However, recent data have demonstrated that the expan-
sion of the pre-B cell pool is not only controlled by IL-7.
Two papers from the group of C. Paige at the Ontario
Cancer Institute have shown that IL-7 plays different roles
in different stages of B cell development, and that the ex-
pression of the BCR modulates the response to IL-7 (18,
19). Both pro-B and pre-B II cells can be induced to pro-
liferate in culture in the presence of IL-7. However, pre-B
cells proliferate in response to picogram amounts of IL-7,
whereas only nanogram amounts can induce pro-B cells to
divide. The extreme sensitivity of pre-B cells to IL-7 de-
pends on the expression of the pre-BCR, because the abil-
ity of recombination activating gene (RAG)
 
2
 
/
 
2
 
 pro-B cells
to proliferate is increased by an H chain transgene (18). It
has been shown that stromal cells contain IL-7 in the cyto-
 
plasm but release only minimal amounts of it, too small to
be detectable in the supernatant. Pre-B cell lines proliferate
only when they are in direct contact with primary stromal
cells, probably because sufficient concentrations of IL-7 can
be supplied only at the surface of the stromal cells (7). In
vivo, therefore, pre-B cells are provided with low amounts
of IL-7 via intimate contact to stromal cells. It is possible
that under these conditions only pre-B II cells prolifer-
ate, because their threshold of response is lower. Although
IL-7 concentrations may be insufficient to induce prolif-
eration of pro-B cells, they nevertheless suffice to induce
V
 
H
 
®
 
D
 
H
 
J
 
H
 
 rearrangement in pro-B cells. This implies that
either the signaling machinery used by the IL-7R is differ-
ent in pro- and pre-B cells, or that the signal emanating
from the IL-7R is integrated with signals that are simulta-
neously generated by the pre-BCR. Thus, the eventual
outcome of IL-7 signaling would be dependent on the
“signaling context” in which the signal is given. The signal-
ing context is predicted to vary with the absence or presence
of additional receptors and, therefore, with the differentia-
tion stage of the cell. Biochemical studies are necessary to
clarify this point.
Rolink et al. (20) in this issue address the question of the
interplay between IL-7 and the pre-BCR and demonstrate
that they have distinct and overlapping functions in B cell
development. Sorted pro-/pre-B I cells undergo two to
five rounds of proliferation in vitro in the absence of IL-7
and stromal cells. This proliferative expansion requires the
expression of the pre-BCR, because pro-/pre-B I cells of
 
l
 
5
 
2
 
/
 
2
 
 mice do not proliferate under these conditions. After
3–5 d in culture, 
 
.
 
95% of the recovered cells were cytoplas-
mic 
 
m
 
H chain (c
 
m
 
)
 
1
 
, and most of them expressed mIgM, in-
dicating that they had successfully rearranged the L chain
genes. These data demonstrate that the presence of the pre-
BCR is indispensable and sufficient for the proliferation
and differentiation of pre-B cells in vitro, and that the mi-
croenvironment of the bone marrow is not necessary for
these developmental steps. However, Rolink et al. also show
that IL-7 does have a function, because 10–15 times higher
numbers of cells can be recovered after culture in saturating
concentrations of IL-7. This is mainly due to the rescue of
pro-/pre-B I cells that failed to produce a functional pre-
BCR. The number of cells that express c
 
m
 
 and mIgM is in-
creased to a lesser extent. Therefore, the expression of a
functional pre-BCR is sufficient to direct a developmental
program that includes few rounds of proliferation followed
by L chain rearrangement and differentiation to mIgM B
cells. IL-7 increases proliferation, but does not induce dif-
ferentiation.
A final interesting point is addressed by this paper. Single
pro-/pre-B I cells sorted and cultured in microwell plates
proliferate with the same frequency and at the same extent
as in bulk culture. This strongly suggests that the signal ini-
tiated by the pre-BCR does not depend on an external
ligand. The pre-BCR, similarly to the BCR, organizes a
complex of signaling molecules in proximity of the cell
membrane (21). The presence of this complex may be suf-
ficient to generate a constitutive signal, which changes the 
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signaling context of the cell and causes the last proliferation
and differentiation steps.
It is important to realize that IL-7 also plays a role in the
development of T cells. Its function is different in 
 
g
 
/
 
d
 
 and
 
a/b
 
 T cells. IL-7 controls germline transcription and rear-
rangement in the TCR-
 
g
 
 locus (22). In 
 
a
 
/
 
b
 
 T cells, IL-7 in-
stead promotes survival and proliferation. Interestingly, it has
been shown recently that the development of 
 
a
 
/
 
b
 
 T cells is
driven by independent and overlapping signals generated by
IL-7 and by the pre-TCR (23). Therefore, the interplay be-
tween their lineage-specific receptors (pre-BCR, pre-TCR)
and IL-7 regulates development in both B and T cells.
The development of pro- and pre-B cells is a clear ex-
ample of how the microenvironment and the expressed re-
ceptors cooperate to decide upon the fate of a cell (Fig. 1).
Pro-B cells receive signals from the IL-7R, which induces
V
 
H
 
®
 
D
 
H
 
J
 
H
 
 rearrangement. At the pre-B II cell stage, these
signals are then integrated with those generated by the pre-
BCR complex, resulting in extensive cell proliferation. As
soon as the pre-B II cells are deprived of the IL-7 signal, ei-
ther because contact to stromal cells is lost or because the
expression of the IL-7R is downregulated (18), only the
pre-BCR guides its development. Proliferation stops, rear-
rangement is induced on the L chain locus, and the BCR is
assembled. The BCR also generates signals in the absence
of antigen; it is indispensable for the survival of mature B
cells in the periphery (24).
 
The work described above demonstrates that in B cells,
commitment, proliferation, differentiation, survival, and all
developmental steps are regulated by the finely tuned bal-
ance between cell-autonomous mechanisms (pre-BCR,
BCR) and signals provided by the microenvironment (IL-7,
TSLP). This leads to the selective development of B cells,
which are fit for their function because they express a cor-
rectly assembled pre-BCR, and are fit for their environ-
ment because they respond to cytokines. Stromal cells pro-
duce and release IL-7. Therefore, they play an important
role in the regulation of B cell development in the bone
marrow, mainly controlling the size of the B cell compart-
ment (from commitment to the pre-B cell stage). In the
bone marrow, different types of hematopoietic cells develop.
It is reasonable to hypothesize that different types of stro-
mal cells exist and organize lineage-specific microenviron-
ments (5). The structure created by the stromal cells is of-
ten considered a fixed characteristic of the bone marrow
that reproducibly regulates the production of a defined
number of cells of each lineage. However, the number of B
cells produced from the bone marrow changes with age (7)
and appears to be regulated by the size of the peripheral B
cell pool (25). Therefore, a mechanism must be postulated
that controls the plasticity of the bone marrow microenvi-
ronment and regulates the function or the number of stro-
mal cells able to produce IL-7 and, eventually, the number
of newly produced B cells.
Figure 1. The interplay be-
tween IL-7 and the pre-BCR in
the bone marrow. Stromal cells
produce and release IL-7. Pro-B
cells of fraction A (green) express
the IL-7R, and their Ig H chain
genes are in germline or DH-JH
configuration. VH®DHJH rear-
rangement is induced in pro-/
pre-B I cells of fraction B–C af-
ter an IL-7–generated signal (red).
At the large pre-B II cell stage,
the expression of the pre-BCR
generates a constitutive signal
(blue), which is integrated with
the signal induced by IL-7 (red).
Pre-B cells progressively lose the
contact to stromal cells and
downregulate the IL-7R. At this
point, they exclusively depend
on the pre-BCR for the last
phases of development. Imma-
ture B cells (light gray) express a
complete BCR. The top line
represents the B cell develop-
mental pathway in normal mice.
The color code indicates the de-
velopmental phases that depend
on IL-7 (red) or on the BCR
(blue). The other lines show the
developmental block seen in
mutant mice. The thin blue line
shows that in the indicated mu-
tant mice pre-BCR–dependent
development can proceed, but
without extensive proliferation. 
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